PCNA PROLIFERATING CELL NUCLEAR ANTIGEN ANTIBODY Test
At DNA Labs UAE, we offer the PCNA PROLIFERATING CELL NUCLEAR ANTIGEN ANTIBODY test to detect the presence of antibodies against PCNA in the blood. This test is primarily used in research settings to study cell proliferation and investigate diseases associated with abnormal cell growth, such as cancer.
Test Details
The PCNA (proliferating cell nuclear antigen) antibody test is a laboratory test that measures the levels of antibodies against PCNA in the blood. PCNA is a protein that plays a crucial role in DNA replication and repair, and its levels increase during cell division. By detecting the presence of these antibodies, the test can provide valuable information about immune responses to abnormal cell proliferation.
Test Components and Cost
The PCNA PROLIFERATING CELL NUCLEAR ANTIGEN ANTIBODY test is priced at 3160.0 AED. The test requires a sample condition of 2 mL (1 mL min.) serum from 1 SST. The sample should be shipped refrigerated or frozen. Additionally, a duly filled Test Send Out Consent Form is mandatory for test processing.
Report Delivery
The sample should be sent by the 7th of the month, and the report will be delivered after 2-3 weeks.
Test Method
The PCNA PROLIFERATING CELL NUCLEAR ANTIGEN ANTIBODY test is conducted using the Indirect Immunofluorescence Assay method. This method allows for the detection of immune complexes formed by the binding of PCNA antibodies to a known antigen.
Test Type
The PCNA PROLIFERATING CELL NUCLEAR ANTIGEN ANTIBODY test is primarily used for the diagnosis of autoimmune disorders. It is commonly requested by Rheumatologists.
Pre Test Information
A duly filled Test Send Out Consent Form is mandatory for test processing. Please ensure that this form is completed before sending your sample.
Important Considerations
It is important to note that a positive result on the PCNA PROLIFERATING CELL NUCLEAR ANTIGEN ANTIBODY test does not necessarily indicate the presence of cancer or any specific disease. Further evaluation and diagnostic tests may be required to determine the underlying cause of the positive result.
Additionally, it is worth mentioning that the PCNA PROLIFERATING CELL NUCLEAR ANTIGEN ANTIBODY test is not commonly used in routine clinical practice for diagnostic purposes. It is mainly utilized in research and specialized laboratories.
| Test Name | PCNA PROLIFERATING CELL NUCLEAR ANTIGEN ANTIBODY Test |
|---|---|
| Components | |
| Price | 3160.0 AED |
| Sample Condition | 2 mL (1 mL min.) serum from 1 SST. Ship refrigeratedor frozen. Duly filled Test Send Out Consent Formis mandatory. |
| Report Delivery | Sampleby7thofthemonth;Report after2??3weeks |
| Method | Indirect Immunofluorescence Assay |
| Test type | Autoimmune disorders |
| Doctor | Rheumatologist |
| Test Department: | OS |
| Pre Test Information | Duly filled Test Send Out Consent Formis mandatory. |
| Test Details | The PCNA (proliferating cell nuclear antigen) antibody test is a laboratory test used to detect the presence of antibodies against PCNA in the blood. PCNA is a protein that plays a crucial role in DNA replication and repair, and its levels increase during cell division. The PCNA antibody test is primarily used in research settings to study cell proliferation and to investigate diseases associated with abnormal cell growth, such as cancer. It can also be used to assess the effectiveness of cancer treatments and monitor disease progression. During the test, a blood sample is taken from the patient, and the serum is isolated. The serum is then mixed with a known antigen that contains PCNA. If the patient has antibodies against PCNA in their blood, these antibodies will bind to the antigen, forming immune complexes. The presence of these immune complexes is then detected using various techniques, such as enzyme-linked immunosorbent assay (ELISA) or immunoblotting. A positive result on the PCNA antibody test indicates that the patient has antibodies against PCNA in their blood, suggesting an immune response to abnormal cell proliferation. However, it is important to note that a positive result does not necessarily mean the patient has cancer or any other specific disease. Further evaluation and diagnostic tests may be required to determine the underlying cause of the positive result. It is also worth mentioning that the PCNA antibody test is not commonly used in routine clinical practice for diagnostic purposes. It is mainly used in research and specialized laboratories. |
